Gemcitabine (G) plus capecitabine (C) versus G alone in locally advanced or metastatic pancreatic cancer. A randomized phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG)

Herrmann, R.; Bodoky, G.; Ruhstaller, T.; Glimelius, B.; Saletti, P.; Bajetta, E.; Schueller, J.; Bernhard, J.; Dietrich, D.; Scheithauer, W.

doi:10.1200/jco.2005.23.16_suppl.lba4010

Back

Journal article

Gemcitabine (G) plus capecitabine (C) versus G alone in locally advanced or metastatic pancreatic cancer. A randomized phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG)

Herrmann, R. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria
Bodoky, G. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria
Ruhstaller, T. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria
Glimelius, B. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria
Saletti, P. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria
Bajetta, E. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria
Schueller, J. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria
Bernhard, J. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria
Dietrich, D. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria
Scheithauer, W. Univ Hosp, Basel, Switzerland; St. Laszlo Hosp, Budapest, Hungary; Cantonal Hosp, St. Gallen, Switzerland; Univ Hosp, Uppsala, Sweden; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; National Cancer Institute, Milano, Italy; Rudolfstiftung, Vienna, Austria; Univ Hosp, Zürich, Switzerland; SAKK Coordinating Ctr, Bern, Switzerland; Univ Hosp, Vienna, Austria

Published in:

Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2005, vol. 23, no. 16_suppl, p. LBA4010-LBA4010

Language

English

Open access status

closed

Identifiers

DOI 10.1200/jco.2005.23.16_suppl.lba4010
ISSN 0732-183X

Persistent URL

https://sonar.ch/global/documents/208963

Statistics

Document views: 12 File downloads: